Abstract:Background: As the major microtubule organizing center in animal cells, the centrosome is implicated with human breast tumor in multiple ways, such as promotion of tumor cell immune evasion. Here, we aimed to detect the expression of centrosome-related genes (CRGs) in normal and malignant breast tissues, and construct a novel centrosome-related prognostic model to discover new biomarkers and screen drugs for breast cancer. Methods: We collected CRGs from the public databases and literature. The differentially expressed CRGs between normal and malignant breast tissues were identified by the DESeq2. Univariate Cox and LASSO regression analyses were conducted to screen candidate prognostic CRGs and develop a centrosome-related signature (CRS) to score breast cancer patients. We further manipulated and visualized data from TCGA, GEO, IMvigor210, TCIA and TIMER to explore the correlation between CRS and patient outcomes, clinical manifestations, mutational landscapes, tumor immune microenvironments, and responses to diverse therapies. Single cell analyses were performed to investigate the difference of immune cell landscape between high- and low-risk group patients. In addition, we constructed a nomogram to guide clinicians in precise treatment. Results: A total of 726 CRGs were collected from the public databases and literature. PSME2 , MAPK10 , EIF4EBP1 were screened as the prognostic genes in breast cancer. Next, we constructed a centrosome-related prognostic signature and validated its efficacy based on the genes for predicting the survival of breast cancer patients. The high-risk group patients had poor prognoses, the area under the ROC curve for 1-, 3-, and 5-year overall survival (OS) was 0.77, 0.67, and 0.65, respectively. The predictive capacity of CRS was validated by other datasets from GEO dataset. In addition, high-risk group patients exhibited elevated level of mutational landscapes and decreased level of immune infiltration, especially T and B lymphocytes. In terms of treatment responses, patients in the high-risk group were found to be resistant to immunotherapy but sensitive to chemotherapy. Moreover, we screened a series of candidate anticancer drugs with high sensitivity in the high-risk group. Conclusion: Our work exploited a centrosome-related prognostic signature and developed a predictive nomogram capable of accurately predicting breast cancer OS. The above discoveries provide deeper insights into the vital roles of the centrosome and contribute to the development of personalized treatment for breast cancer.

Centrosomal-associated Proteins: Potential therapeutic targets for solid tumors?

Centrosomes and associated proteins in pathogenesis and treatment of breast cancer

A Look into the Link Between Centrosome Amplification and Breast Cancer

Centrosome Duplication and Regulation

The Centrosome in Normal and Transformed Cells

Centromeres in cancer: Unraveling the link between chromosomal instability and tumorigenesis

Overcome Cancer Drug Resistance by Targeting Epigenetic Modifications of Centrosome

Centrosome Dysfunction: a Link Between Senescence and Tumor Immunity

Centrosome Dynamics and Its Role in Inflammatory Response and Metastatic Process

Proteomic Mapping and Targeting of Mitotic Pericentriolar Material in Tumors Bearing Centrosome Amplification

Chromosome aberrations associated with centrosome defects: a study of comparative genomic hybridization in breast cancer

Expression of centrosomal tubulins associated with DNA ploidy in breast premalignant lesions and carcinoma.

[Correlations of Centrosome Abnormality and Genomic Instability to Tumor].

Amplified centrosomes—more than just a threat

[Centrosome Hyperamplificationin Oral Precancerous Lesions and Squamous Cell Carcinomas].

An updated view on the centrosome as a cell cycle regulator

Four centrosome-related genes to predict the prognosis and drug sensitivity of patients with colon cancer

Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis

A pan-cancer landscape of centromere proteins in tumorigenesis and anticancer drug sensitivity

Identification of a centrosome-related prognostic signature for breast cancer

Immune Infiltration Related CENPI Associates with the Malignant Features and Drug Resistance of Lung Adenocarcinoma.